Humpa, Karen .
HRN: 07-62-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2022
DOXYCYCLINE 100MG (CAP)
09/22/2022
10/06/2022
ORAL
100 Mg
BID
Post Pelvic Lap; Sexually Transmitted Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes